Sub-type C infection does not increase the risk of virologic failure when people are taking tenofovir-containing first-line ART
UN High-Level Meeting on Ending AIDS faces battle over key populations
HIV self-testing has several advantages, but some barriers to HIV testing likely to remain
Australia shows an alternative to rationing hepatitis C treatment
Significant attrition at each stage of HIV care cascade in South Africa
Cost is biggest barrier to PrEP in Europe, ECDC report declares
France to provide universal access to hepatitis C treatment
Many South African people whose HIV has been diagnosed have unprotected sex with a serodiscordant partner before starting ART
Two million people with HIV started treatment in 2015
